This one is a bit of a cheat, but we would be remiss if we didn’t mention the Dragon Ball Heroes transformation that saw Cell inheriting the power of a Dark Dragon Ball, transforming himself into ...
A new treatment may be in sight for stroke patients after scientists successfully reprogrammed immune cells to replace damaged brain cells and restore brain function after stroke-like injury. Every ...
SAN DIEGO--(BUSINESS WIRE)--Escient Pharmaceuticals, a clinical-stage company advancing novel small molecule therapeutics for the potential treatment of a broad range of neurosensory-inflammatory ...
Researchers have determined that type II innate lymphoid cells (ILC2s), a type of immune cell, can change its characteristics and functions after a cancer patient receives stem cells from a donor, ...
Daiichi Sankyo and Merck are pioneering a revolutionary approach in SCLC treatment with ifinatamab deruxtecan (I-DXd), which has secured Breakthrough Therapy Designation from the FDA for adult ...
CAMBRIDGE, Mass., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today ...
CULVER CITY, Calif.--(BUSINESS WIRE)--NantKwest Inc. (Nasdaq: NK), a next generation, clinical-stage immunotherapy company focused on harnessing the unique power of our immune system using natural ...
Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy: ECOG-ACRIN E2810 Sixty-nine ...
Over the past decade, developments in the treatment of advanced-stage non-small cell lung cancer have resulted in promising long-term survival rates that were not the case years ago, according to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback